Ocugen, Inc. OCGN
1.02
0.02
2.00%
as of 25 Sep
- Market cap
- $339.1M
- P/E
- 0.0×
Follow OCGN
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
92.28 | 91.83 | 132.78 | 113.14 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(38.37) | (29.03) | (27.20) | (42.48) | |
P/B ratio |
140.26 | 0.00 | 102.13 | 0.00 | |
Price to Tangible BV |
148.67 | 0.00 | 105.77 | 0.00 | |
EV/Sales |
91.75 | 94.14 | 132.18 | 91.68 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(9.23) | (7.29) | (9.94) | (6.90) | |
EV/FCF |
(9.20) | (7.27) | (9.91) | (6.88) | |
Quick Ratio |
1.60 | 0.81 | 1.54 | 0.75 | |
Current Ratio |
1.85 | 1.06 | 1.86 | 0.80 | |
Net Debt/EBITDA |
0.25 | (0.64) | 0.16 | 7.05 | |
Debt/Assets |
49.31% | 66.16% | 51.30% | 1.41% | |
Debt/Equity |
8.04 | (2.37) | 5.03 | (0.11) | |
Asset Turnover |
0.09 | 0.07 | 0.07 | 0.05 | |
Operating CF/Net income |
0.64 | 0.79 | 1.14 | 0.49 | |
Capex/Depreciation |
(0.10) | (0.04) | (0.01) | (0.01) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
636.36% | (5,528.50%) | 734.18% | 718.41% | |
Selling, General and Administrative Expense of Revenue |
469.63% | (3,177.20%) | 529.48% | 486.69% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
112.73% | (1,037.31%) | 221.66% | 123.19% | |
Graham Net Nets |
(0.03) | (0.08) | (0.02) | (0.07) | |
Graham Number |
0.00 | 0.46 | 0.00 | 0.53 | |
Earnings Yield |
(13.50%) | (17.04%) | (13.26%) | (16.99%) | |
Free Cash Flow Yield |
(10.80%) | (14.10%) | (10.05%) | (11.78%) | |
Revenue per Share |
0.01 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.04) | (0.05) | (0.07) | (0.04) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.04) | (0.05) | (0.07) | (0.04) | |
Cash per Share |
0.11 | 0.06 | 0.10 | 0.30 | |
Shareholders Equity per Share |
0.01 | (0.04) | 0.02 | (0.05) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.01 | (0.04) | 0.02 | (0.05) | |
Free Cash Flow |
(13.01) | (14.00) | (21.80) | (12.22) | |
Working Capital |
17.28 | 1.30 | 17.84 | (26.36) | |
Capital Expenditures |
(0.09) | (0.03) | (0.01) | (0.02) | |
Net Current Asset Value |
(16.42) | (31.34) | (12.55) | (34.04) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.05 | (0.18) | 0.00 | 0.01 | |
Net Profit Margin |
(1,144.46%) | 9,174.09% | (1,250.95%) | (1,671.84%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Payables |
3.03 | 5.22 | 3.23 | 4.69 | |
Average Assets |
59.77 | 62.98 | 60.68 | 88.90 | |
Average Common Equity |
22.08 | 8.73 | 10.86 | (6.75) |
Columns are period end dates